title: Cell replacement therapies: is it time to reprogram?
abstract: Hematopoietic stem cell transplantations have become a very successful therapeutic approach to treat otherwise life-threatening blood disorders. It is thought that stem cell transplantation may also become a feasible treatment option for many non-blood-related diseases. So far, however, the limited availability of human leukocyte antigen-matched donors has hindered development of some cell replacement therapies. The Nobel-prize rewarded finding that pluripotency can be induced in somatic cells via expression of a few transcription factors has led to a revolution in stem cell biology. The possibility to change the fate of somatic cells by expressing key transcription factors has been used not only to generate pluripotent stem cells, but also for directly converting somatic cells into fully differentiated cells of another lineage or more committed progenitor cells. These approaches offer the prospect of generating cell types with a specific genotype de novo, which would circumvent the problems associated with allogeneic cell transplantations. This technology has generated a plethora of new disease-specific research efforts, from studying disease pathogenesis to therapeutic interventions. Here we will discuss the opportunities in this booming field of cell biology and summarize how the scientists in the Netherlands have joined efforts in one area to exploit the new technology.
authors.affiliation: 1 Department of Molecular Cell Biology, Leiden University Medical Center , 2300RC Leiden, The Netherlands .
authors.forename: Harald M
authors.initials: HM
authors.lastname: Mikkers
authors.forename: Christian
authors.initials: C
authors.lastname: Freund
authors.forename: Christine L
authors.initials: CL
authors.lastname: Mummery
authors.forename: Rob C
authors.initials: RC
authors.lastname: Hoeben
mesh_terms: D000818:Animals; D002454:Cell Differentiation; D064987:Cell- and Tissue-Based Therapy / Q000009:adverse effects / Q000379:methods / Q000639:trends; D065150:Cellular Reprogramming; D006801:Humans; D009426:Netherlands; D057905:Stem Cell Research; D033581:Stem Cell Transplantation / Q000009:adverse effects / Q000379:methods / Q000639:trends; D013234:Stem Cells / Q000166:cytology / Q000378:metabolism